For the luminal A and luminal B (HER2-negative) subtypes, the nature of the change in the content of cytokines practically coincided (Figure 4), and the maximum differences from the control group were shown for triple-negative breast cancer. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.